sp2-Iminosugars targeting human lysosomal β-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease
The late-onset form of Tay-Sachs disease displays when the activity levels of human β-hexosaminidase A (HexA) fall below 10% of normal, due to mutations that destabilise the native folded form of the enzyme and impair its trafficking to the lysosome. Competitive inhibitors of HexA can rescue disease...
Saved in:
| Main Authors: | Manuel González-Cuesta, Irene Herrera-González, M. Isabel García-Moreno, Roger A. Ashmus, David J. Vocadlo, José M. García Fernández, Eiji Nanba, Katsumi Higaki, Carmen Ortiz Mellet |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2022.2073444 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GM2 Gangliosidosis (Tay-Sachs Disease), type I, Infantile Form: Clinical Case
by: Artem A. Babkin, et al.
Published: (2024-09-01) -
GM2-gangliosidosis, type I (Tay – Sachs disease) in the pediatrician practice
by: Natalia V. Zhurkova, et al.
Published: (2021-01-01) -
Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease
by: Jacky M. Guerrero-Vargas, et al.
Published: (2025-05-01) -
Characterization of recombinant human lysosomal beta-hexosaminidases produced in the methylotrophic yeast Pichia pastoris
by: Angela Johana Espejo Mojica, et al.
Published: (2016-08-01) -
Iminosugars of the Invasive Arboreal <i>Amorpha fruticosa</i> and Glycosidase Inhibition Potential
by: Robert J. Nash, et al.
Published: (2025-07-01)